McDermott Will & Emery advised Advicenne on the deal.Advicenne, a pharmaceutical company specializing in the development and commercialization of innovative treatments for those suffering from rare…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
